Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia. 1985

D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney

d-Amphetamine (20 mg) was administered intravenously in a double-blind design to 17 schizophrenic patients with and without concurrent 3-week lithium carbonate pretreatment to evaluate the lithium attenuation of d-amphetamine effects which we had observed in affective disorder patients. Lithium significantly attenuated the acute d-amphetamine-induced changes in an activation-euphoria cluster and in the mannerisms and posturing item of the Brief Psychiatric Rating Scale. Because the psychosis-increasing effects of d-amphetamine were not significantly decreased, it is conceivable that the d-amphetamine-induced changes in activation and euphoria and in psychosis are regulated by different dopamine mechanisms. The small clinical effects seen at 3 weeks of lithium treatment in schizophrenic patients could be mediated by dopamine.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011605 Psychoses, Substance-Induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance. Psychoses, Drug,Psychoses, Toxic,Substance-Induced Psychoses,Toxic Psychoses,Drug Psychoses,Psychoses, Substance Induced,Substance Induced Psychoses
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003913 Dextroamphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. d-Amphetamine,Curban,Dexamfetamine,Dexamphetamine,Dexedrine,Dextro-Amphetamine Sulfate,DextroStat,Dextroamphetamine Sulfate,Oxydess,d-Amphetamine Sulfate,dextro-Amphetamine,Dextro Amphetamine Sulfate,Sulfate, Dextroamphetamine,d Amphetamine,d Amphetamine Sulfate,dextro Amphetamine
D005059 Euphoria An exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states. Euphorias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
February 2015, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
March 2015, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
February 2004, Revue medicale de Liege,
D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
June 1996, The American journal of psychiatry,
D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
January 1995, Pharmacology, biochemistry, and behavior,
D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
February 1997, Pharmacology, biochemistry, and behavior,
D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
January 1986, Psychopharmacology,
D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
May 1975, The Western journal of medicine,
D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
January 1989, Psychopharmacology,
D P van Kammen, and J P Docherty, and S R Marder, and J E Rosenblatt, and W E Bunney
January 1973, The American journal of psychiatry,
Copied contents to your clipboard!